Brigit Biofarmaka Teknologi Tbk PT (OBAT)

Currency in IDR
398.00
0.00(0.00%)
Closed·
OBAT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
OBAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
390.00404.00
52 wk Range
308.001,030.00
Key Statistics
Bid/Ask
394.00 / 398.00
Prev. Close
398
Open
402
Day's Range
390-404
52 wk Range
308-1,030
Volume
1.48M
Average Volume (3m)
14.68M
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OBAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Brigit Biofarmaka Teknologi Tbk PT Company Profile

PT Brigit Biofarmaka Teknologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, hair serum, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products. The company was founded in 2015 and is based in Sukoharjo, Indonesia.

Industry
-
Sector
-
Employees
24
Market
Indonesia

Compare OBAT to Peers and Sector

Metrics to compare
OBAT
Peers
Sector
Relationship
P/E Ratio
7.8x13.1x12.2x
PEG Ratio
0.140.050.03
Price/Book
2.3x1.2x1.5x
Price / LTM Sales
1.9x0.8x0.9x
Upside (Analyst Target)
-35.0%16.7%
Fair Value Upside
Unlock25.6%10.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 51.06%
Dividend Yield
5.62%
Industry Median -
Annualised payout
22.37
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 05, 2025
EPS / Forecast
11.19 / --
Revenue / Forecast
29.01B / --
EPS Revisions
Last 90 days

OBAT Income Statement

People Also Watch

450
BRMS
-1.75%
4,670
BMRI
-0.21%
3,700
BBRI
-0.27%
8,300
BBCA
0.00%

FAQ

What Stock Exchange Does Brigit Biofarmaka Teknologi Tbk PT Trade On?

Brigit Biofarmaka Teknologi Tbk PT is listed and trades on the Jakarta Stock Exchange stock exchange.

What Is the Stock Symbol for Brigit Biofarmaka Teknologi Tbk PT?

The stock symbol for Brigit Biofarmaka Teknologi Tbk PT is "OBAT."

What Is the Brigit Biofarmaka Teknologi Tbk PT Market Cap?

As of today, Brigit Biofarmaka Teknologi Tbk PT market cap is 238.80B.

What Is Brigit Biofarmaka Teknologi Tbk PT's Earnings Per Share (TTM)?

The Brigit Biofarmaka Teknologi Tbk PT EPS (TTM) is 51.06.

From a Technical Analysis Perspective, Is OBAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Brigit Biofarmaka Teknologi Tbk PT Stock Split?

Brigit Biofarmaka Teknologi Tbk PT has split 0 times.

How Many Employees Does Brigit Biofarmaka Teknologi Tbk PT Have?

Brigit Biofarmaka Teknologi Tbk PT has 24 employees.

What is the current trading status of Brigit Biofarmaka Teknologi Tbk PT (OBAT)?

As of 10 Aug 2025, Brigit Biofarmaka Teknologi Tbk PT (OBAT) is trading at a price of 398.00, with a previous close of 398.00. The stock has fluctuated within a day range of 390.00 to 404.00, while its 52-week range spans from 308.00 to 1,030.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.